Jim is a bioprocess and biopharmaceutical expert with nearly 30 years of experience in the biopharma sector. Expertise of manufacturing technical due diligence, technology assessment, and company acquisition technical due diligence. Jim has held senior roles, including CEO and VP level positions, at companies including Xenova Research Ltd., Cantab Biopharmaceuticals and Abzena PLC. Jim holds a PhD in Biochemistry from the University of Leicester, UK.
Skills includes:
- Senior technical operation
- Senior leadership experience
- Prokaryotic and eukaryotic cell expression
- Products: proteins & fusion proteins, antibodies, vaccines, live-viruses (including ATMPs), live-bacteria, ADCs
- Bioprocess development; UPS & DSP and analytical development
- Early phase and late phase experience
- Quality by Design (QbD) approaches
- GMP manufacturing facility design
- Expertise in CMC product development planning and manufacturing strategy development
- Manufacturing technical due diligence & technology assessment
- Extensive experience working in Europe and the USA
